Journal: Current Drug Abuse Reviews Volume: 5 Issue: 2 Year: 2012 Page: 158-168 Author(s): John C. Ashton
Journal: Current Pharmaceutical Design Volume: 22 Issue: 42 Year: 2016 Page: 6420-6425 Author(s): Laurent Karila,Amine Benyamina,Lisa Blecha,Olivier Cottencin,Joël Billieux
Journal: CNS & Neurological Disorders - Drug Targets Volume: 16 Issue: 5 Year: 2017 Page: 567-575 Author(s): Giovanni Martinotti,Rita Santacroce,Duccio Papanti,Yasmine Elgharably,Mariya Prilutskaya,Ornella Corazza
Journal: Current Pharmaceutical Design Volume: 6 Issue: 1 Year: 2000 Page: 1347-1359 Author(s): Emil Pop
Journal: Current Pharmaceutical Design Volume: 20 Issue: 25 Year: 2014 Page: 4106-4111 Author(s): Olivier Cottencin,Benjamin Rolland,Laurent Karila
Journal: Current Neuropharmacology Volume: 19 Issue: 11 Year: 2021 Page: 2038-2048 Author(s): Davide Radaelli,Alessandro Manfredi,Martina Zanon,Paolo Fattorini,Matteo Scopetti,Margherita Neri,Paolo Frisoni,Stefano DâErrico
Journal: Current Drug Targets - CNS & Neurological Disorders Volume: 4 Issue: 5 Year: 2005 Page: 507-530 Author(s): Franjo Grotenhermen
Journal: Recent Patents on CNS Drug Discovery (Discontinued) Volume: 4 Issue: 2 Year: 2009 Page: 112-136 Author(s): Ahmed M. Galal, Desmond Slade, Waseem Gul, Abir T. El-Alfy, Daneel Ferreira, Mahmoud A. Elsohly
Journal: Current Pharmaceutical Design Volume: 22 Issue: 42 Year: 2016 Page: 6380-6391 Author(s):
Journal: CNS & Neurological Disorders - Drug Targets Volume: 16 Issue: 5 Year: 2017 Page: 554-566 Author(s): Ana Lucia Arellano,Esther Papaseit,Anna Romaguera,Marta Torrens,Magi Farré
Previous Next